However, gene knockout studies suggested that CDC42 might function as a tumor suppressor, because targeted ablation of CDC42 gene in the hepatocytes or blood stem/progenitor cells resulted in the development of hepatocellular carcinoma or myeloproliferative disease in mice [16, 17]. This evidence concerns the gene CDC42 and hepatocellular carcinoma.